No Data
No Data
No Data
No Data
No Data
The controlling shareholder of Guanhao Biology (300238.SZ) pledges 14.65 million shares
Guanhao Biology (300238.SZ) announced that the company recently received Guangdong Zhiguang Biotechnology Co., Ltd., the controlling shareholder of the company...
Zhitong FinanceApr 10 04:44 ET
Guanhao Biology (300238.SZ): As of March 20, 2024, the total number of shareholders of the company was 31,042
Gelonghui March 21丨Guanhao Biotech (300238.SZ) said on the investor interactive platform that as of March 20, 2024, the total number of shareholders of the company was 31,042.
Gelonghui FinanceMar 21 03:50 ET
Optimistic Investors Push Guanhao Biotech Co.,Ltd. (SZSE:300238) Shares Up 26% But Growth Is Lacking
Those holding Guanhao Biotech Co.,Ltd. (SZSE:300238) shares would be relieved that the share price has rebounded 26% in the last thirty days, but it needs to keep going to repair the recent damage it
Simply Wall StMar 18 20:33 ET
Guan Hao Biology (300238.SZ): No plans to participate in the brain-computer interface conference
Gelonghui March 12 丨 Guanhao Biology (300238.SZ) said on the investor interactive platform that the company has no plans to participate in the brain-computer interface conference yet.
Gelonghui FinanceMar 12 03:22 ET
Guanhao Biotech (300238.SZ): 2023 net profit of 31.058 million yuan reversed year-on-year losses
Gelonghui March 5 | Guanhao Biotech (300238.SZ) released its 2023 annual report. In 2023, the company achieved operating income of 404 million yuan, an increase of 7.13% over the previous year; net profit attributable to shareholders of listed companies was 31.058 million yuan, which turned a year-on-year loss into a profit; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 305.554 million yuan; and basic earnings per share were 0.12 yuan.
Gelonghui FinanceMar 5 07:37 ET
Express News | China Brain Stocks Up After Report on Musk's Neuralink Patient
Moomoo 24/7Feb 20 21:02 ET
No Data
No Data